MedTrace Logo

Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection

NCT04369807 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 693

Last updated 2025-12-05

No results posted yet for this study

Summary

A prospective, longitudinal, observational cohort study looking at patients following COVID-19 disease using multi-parametric magnetic resonance imaging (MRI) to assess the degree and prevalence of organ injury.

Conditions

Interventions

DIAGNOSTIC_TEST

Outpatient MRI

Participation in the study includes up to 3 visits to a partnering imaging facility - this will include measurement of height and weight (to calculate BMI), blood pressure measurement, 3 sets of blood tests, 3 Questionnaires and 3 MRI tests. There will be no medical interventions as part of the study. All participants will receive standard-of-care by their healthcare provider/s. With the participant's consent, the participant's primary care physician will be made aware of their participation in the study. Furthermore, participants will be informed of any structural abnormalities found in the MRI scan (e.g. abnormal vessels, haemangioma, tumour, cyst, among others) and abnormal blood test results as these may have clinical implications.

Sponsors & Collaborators

  • Perspectum

    lead INDUSTRY

Principal Investigators

  • Rajarshi Banerjee, MSc, DPhil · Honorary Consultant Physician, Oxford University NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-21
Primary Completion
2022-04-19
Completion
2022-04-19

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04369807 on ClinicalTrials.gov